This prevents introducing contaminants that could degrade the peptide or cause injection site reactions
Glutamine synthetase (GS), which is found in astrocytes, is the only known enzyme to date that is capable of a reversible conversion between glutamine and glutamate and ammonia in the mammalian brain [28]
Daily injections over weeks allow cumulative peptide buildup in retinal tissues explaining delayed onset of benefits (several weeks typical in studies)
It primarily focuses on healing and recovery, though it can be used alongside growth hormone-boosting peptides for better overall results
When human cells are integrated into microfluidic platforms that mimic key physiological parameters, including oxygen gradients, fluid flow, and multicellular tissue interactions, these systems provide improved translational relevance than conventional models [175, 176]